Virtus ETF Advisers’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Virtus ETF Advisers’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,147	Closed	-$275K	–	162
2016 Q1	$275K	Hold	5,147	–	–	0.38%	60
2015 Q4	$581K	Buy	+5,147	New	+$567K	1.59%	24

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Virtus ETF Advisers's ANAC Position: Q2 2016 in Review

Virtus ETF Advisers sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 5,147 shares — an estimated $275K sold.

Virtus ETF Advisers first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $581K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Virtus ETF Advisers reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Virtus ETF Advisers sold 5,147 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $275K.
Virtus ETF Advisers first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
Virtus ETF Advisers's ANACOR PHARMACEUTICALS INC COM position peaked at $581K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Virtus ETF Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.